Home Conference Coverage ASCO 2022

ASCO 2022

The Importance of Time at Home Among Older AML Patients

Analyzing the Prognostic Significance of Measurable Residual Disease Testing Before Allogeneic Transplantation in AML...

What Causes Treatment Failure in Acute Myeloid Leukemia with KMT2Ar?

Assessing Clinical Outcomes of Patients with Hematological Malignancies and Left-Ventricular Assisted Device (LVAD) Managed...

Assessing Autologous CD7-targeted CAR T-cell Therapy for Acute Lymphoblastic Leukemia/Lymphoma

Updated Data on a Phase I Trial of Donor-Derived CD7 CAR T Cells for...

Analyzing Mortality and Survival in Acute Promyelocytic Leukemia Using the Charlson Comorbidity Index

Assessing Clinical Characteristics and Treatment Outcomes in de novo Myeloid Sarcoma

Whole-Genome Sequencing as an Alternative to Analyze Copy Number Abnormalities in AML, MDS and...

Identifying Clinical Predictors of VTE in AML and MDS

Load more
Subscribe to RSS